Avacta Group PLC (AVCT)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

32.00p

Buy

34.00p

arrow-down-0.25p (-0.75%)

Avacta Group PLC is a United Kingdom based company, which caters to the healthcare sector. It develops medical diagnostic products such as reagents and arrays which are helpful in drug discovery.
Prices updated at 01 May 2025, 17:07 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Shaun Edward Chilton
CEO
Dr. Christina Marie Coughlin
Most recent earnings
31 Dec 2023
Fiscal year end
31 Dec 2023
Employees
148
Head office
Unit 20, Ash Way
Wetherby
United Kingdom
LS23 7FA
mobile
+44 1904217070
letter
investors@avacta.com

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Shaun Edward Chilton
Non-Executive Director, Chairman
-----
Dr. Trevor John Nicholls
Non-Executive Director
-----
Mr. Paul Andrew Fry
Non-Executive Director
-----
Dr. Christina Marie Coughlin
Executive Director, Chief Executive Officer
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
AXA Investment Managers UK Ltd4,344,0620.54125--31 Mar 20251.16
UTM IM GBP AXA Framlington Biotech4,344,0620.54125--31 Mar 20251.16
Unicorn Asset Management Ltd4,300,0000.82491--31 Mar 20251.15
Unicorn AIM VCT Series 3 ORD4,300,0000.82491--31 Mar 20251.15
FIL Life Insurance Limited2,828,0700.03762-64881-31 Mar 20250.76

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
No data
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.